Open AccessClinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma
Author(s) -
Cecilia Monge,
Changqing Xie,
Seth M. Steinberg,
Tim Greten
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s311496
Subject(s) - medicine , hepatocellular carcinoma , immunotherapy , adverse effect , carcinoma , gastroenterology , oncology , survival analysis , survival rate , surgery , cancer
Patients with advanced hepatocellular carcinoma have a dismal prognosis; only a subset of patients with advanced HCC will benefit from treatment with immunotherapy. We searched for clinical characteristics predicting exceptional long-term survival in HCC patients treated with immune checkpoint inhibitors.